← Back
▼ SELL 10b5-1 Plan

$ Value

$900K

Shares

6,560

Price

$137

Filed

Jan 30

Insider

Name

Sampath Anand

Title

EVP, Ops & Clinical Research

CIK

0001406493

Roles

Officer

Transaction Details

Transaction Date

2026-01-28

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

41,105

Footnotes

The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of September 12, 2025, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. | The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $135.94 per share to a high of $136.94 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. | The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $136.95 per share to a high of $137.89 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. | The price reported in Column 4 represents the weighted average purchase price per share. The actual sale prices ranged from a low of $138.07 per share to a high of $138.12 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. | This option was granted on February 29, 2016 and is exercisable as the option vests. The option vested over a 5 year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.

Filing Info

Accession No.

0000937556-26-000008

Form Type

4

Issuer CIK

0000937556

Sampath Anand's History

Date Ticker Type Value
2026-03-06 MASI A $0
2026-01-28 MASI M $1.1M
2026-01-28 MASI $1.6M
2026-01-28 MASI $900K
2026-01-28 MASI $27K
2026-01-28 MASI M $0

Other Insiders at MASI (90d)

Insider Bought Sold Last
Sampath Anand
EVP, Operations
2026-03-06
Sampath Anand
EVP, Ops & Clinical Research
$1.7M 2026-01-28
Szyman Catherine M.
CEO
2026-03-06
Dadswell Charles
EVP, General Counsel
2026-03-06
Young Micah W
EVP & Chief Financial Officer
2026-03-06
Benner Tim
Chief Marketing Officer
2026-03-06
Hellmann Elisabeth A
Chief Human Resources Officer
2026-03-06
Meehan Greg Allen
Chief Commerical Officer
2026-03-06